查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1737111

全球传统创伤护理市场（按产品、应用、最终用户和地区划分） (2026-2032)

Traditional Wound Care Market by Product (Gauze, Tape, Bandage, Cotton), Application (Chronic Wounds, Acute Wounds), End-User (Hospitals, Specialty Clinics, Home Healthcare), & Region for 2026-2032
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

传统创伤护理市场评估（2026-2032）

人们对先进创伤护理产品的认知度不断提升，推动了传统创伤护理市场规模的成长。根据 Verified Market Research 分析师预测，全球传统创伤护理市场规模预计将从 2024 年的约 56.4 亿美元成长至 2032 年的 74.5 亿美元。

传统创伤护理市场的快速扩张主要是由于慢性伤口的盛行率不断上升，刺激了对有效伤口管理解决方案的需求，预计从 2026 年到 2032 年，复合年增长率将达到 3.54%。

传统创伤护理市场定义/概述

传统创伤护理是指用于治疗和管理伤口的方法和产品，包括敷料、绷带和局部药膏。这种方法通常用于轻微割伤、擦伤和手术伤口，透过保湿提供必要的保护，形成一道防感染的屏障，并促进伤口癒合。各种技术，包括湿敷、干敷和纱布敷料，都可用于促进伤口癒合，同时预防创伤护理护理併发症。

全球范围内慢性伤口的日益增多，使得有效伤口管理的重要性日益凸显。人口老化、糖尿病和肥胖症发病率飙升，以及人们对正确创伤护理实践的认识不断提高等因素，正在推动传统创伤护理市场的成长。此外，产品配方的改进和创新技术的整合预计将显着促进市场扩张。

我们的报告包含可操作的数据和前瞻性的分析，可协助您制定宣传方案、建立商业计划、组织简报或撰写提案。

慢性伤口的日益普及如何影响传统创伤护理市场的成长？

慢性伤口的日益普遍被认为是影响传统创伤护理市场成长的关键因素。糖尿病、血管疾病和人口老化等因素正在增加导致伤口癒合缓慢的疾病的发生率。随着患有此类慢性疾病的患者人数不断增加，对有效的伤口管理解决方案的需求也日益增长。世界卫生组织 (WHO) 预测，到 2045 年，糖尿病患者人数将从 2014 年的 4.22 亿增加到 6.29 亿，预计传统创伤护理产品的需求将大幅增长。

因此，传统的创伤护理产品被更频繁地用于满足这些需求，从而增加了市场规模。透过适当的创伤护理持续关注改善患者结果也反映在市场动态中，这推动了传统方法和新技术的采用。

随着先进创伤护理技术的日益普及，传统创伤护理市场面临哪些限制？

随着先进创伤护理技术的日益普及，传统创伤护理市场正面临许多限制。向生物活性敷料和负压创伤护理等更先进、更专业的产品转变，被视为对传统创伤护理方法的潜在挑战。

随着医疗保健提供者采用这些创新解决方案，传统方法可能会被取代，从而限制市场成长。此外，医疗机构的预算限制更青睐可能更有效的先进创伤护理产品。因此，在技术进步日益主导的竞争格局中，传统创伤护理产品可能难以维持市场占有率。

目录

第一章全球传统创伤护理市场简介

  • 市场概览
  • 研究范围
  • 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

4. 全球传统创伤护理市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

5. 全球传统创伤护理市场（按产品）

  • 概述
  • 纱布
  • 磁带
  • 绷带
  • 棉布

6. 全球传统创伤护理市场（按应用）

  • 概述
  • 慢性伤口
  • 急性伤口

7. 全球传统创伤护理市场（依最终使用者）

  • 概述
  • 医院
  • 诊所
  • 家庭医疗保健
  • 其他的

8. 全球传统创伤护理市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区
    • 中东和非洲
    • 南美洲

9. 全球传统创伤护理市场的竞争格局

  • 概述
  • 各公司市场排名
  • 主要发展策略

第十章 公司简介

  • 3M
  • Braun Melsungen AG
  • Coloplast A/S
  • Convatec Group plc
  • Dermarite Industries LLC.
  • Deroyal Industries, Inc.
  • Hollister Incorporated
  • Integra Lifesciences Holdings Corporation
  • Johnson & Johnson Private Limited
  • Medtronic plc.
  • Molnlycke Health Care Ab
  • Paul Hartmann AG
  • Smith & Nephew plc.

第十一章 附录

  • 相关调查
简介目录
Product Code: 51933

Traditional Wound Care Market Valuation - 2026-2032

Increasing awareness of advanced wound care products is driving the market size of the traditional wound care market. According to the analyst from Verified Market Research, the Traditional Wound Care Market is estimated to reach a valuation of USD 7.45 Billion By 2032 over the forecast subjugating around USD 5.64 Billion valued in 2024.

The rapid expansion of the traditional wound care market is primarily driven by the rising prevalence of chronic wounds, which is increasing the demand for effective wound management solutions. It enables the market to grow at a CAGR of 3.54% from 2026 to 2032.

Traditional Wound Care Market: Definition/ Overview

Traditional wound care refers to the methods and products used to treat and manage wounds, which include dressings, bandages, and topical ointments. This approach is often utilized for minor cuts, abrasions, and surgical wounds, providing essential protection and promoting healing through moisture retention and barrier formation against infections. Various techniques, such as wet-to-dry dressings and gauze applications, are employed to facilitate the healing process while preventing complications associated with wound care.

Increasing emphasis is placed on the importance of effective wound management as the global incidence of chronic wounds rises. The growth of the traditional wound care market is supported by factors such as an aging population, a surge in diabetes and obesity rates, and a growing awareness of proper wound care practices. Furthermore, advancements in product formulations and the integration of innovative technologies are expected to contribute significantly to market expansion.

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How is the Increasing Prevalence of Chronic Wounds Impacting the Growth of the Traditional Wound Care Market?

The increasing prevalence of chronic wounds is being recognized as a significant driver affecting the growth of the traditional wound care market. Factors such as diabetes, vascular diseases, and an aging population are contributing to a higher incidence of conditions that result in slow-healing wounds. As the number of individuals suffering from these chronic conditions rises, the demand for effective wound management solutions is being escalated. With the World Health Organization projecting the number of people with diabetes to rise from 422 million in 2014 to 629 million by 2045, the demand for traditional wound care products is expected to surge.

Consequently, traditional wound care products are being utilized more frequently to address these needs, thus leading to an expansion in market size. The ongoing focus on improving patient outcomes through proper wound care is also being reflected in the market dynamics, enhancing the adoption of traditional methods alongside newer technologies.

What Restraints are Being Faced by the Traditional Wound Care Market Due to the Rising Availability of Advanced Wound Care Technologies?

Various restraints are being faced by the traditional wound care market due to the rising availability of advanced wound care technologies. The shift toward more sophisticated and specialized products, such as bioactive dressings and negative pressure wound therapy, is being observed as a potential challenge for traditional wound care methods.

As healthcare providers increasingly adopt these innovative solutions, traditional approaches are being overshadowed, which may limit market growth. Additionally, budget constraints in healthcare facilities are leading to a preference for advanced wound care products, which are often perceived as more effective. As a result, traditional wound care products may struggle to maintain their market share in a competitive landscape increasingly dominated by technological advancements.

Category-Wise Acumens

What is the Dominating Product Segment Within the Traditional Wound Care Market?

According to VMR analyst, the dominating product segment within the traditional wound care market is gauze, which is widely utilized due to its versatility and effectiveness in wound management. Gauze products are preferred for their ability to absorb exudate while allowing airflow to the wound, which is essential for the healing process.

Various types of gauze, including sterile and non-sterile options, are being offered to cater to diverse clinical needs. The widespread availability and cost-effectiveness of gauze are also contributing to its popularity among healthcare providers. As a result, gauze is being recognized as a staple in both hospital and home healthcare settings, further solidifying its position as the leading product in the market.

Why Chronic Wounds is Experiencing Rapid Growth in the Traditional Wound Care Market?

According to VMR analyst, the chronic wounds segment is experiencing rapid growth in the traditional wound care market, which are increasingly being recognized for their complex management requirements. Conditions such as diabetes and venous ulcers are leading to a rise in chronic wounds, necessitating effective treatment solutions.

As the prevalence of these conditions increases, the demand for products specifically designed for chronic wound care is being amplified. Innovative treatment options and enhanced education regarding chronic wound management are also contributing to this growth. Consequently, healthcare providers are focusing on developing tailored care strategies, ensuring that the chronic wound application sub-segment remains at the forefront of market expansion.

Country/Region-wise Acumens

What Factors Contribute to North America's Dominance in the Traditional Wound Care Market?

According to VMR analyst, various factors are contributing to North America's dominance in the traditional wound care market, with a robust healthcare infrastructure being a significant element. High healthcare expenditure in the region is facilitating access to advanced medical technologies and wound care products.

Additionally, the increasing prevalence of chronic wounds, driven by an aging population and rising rates of diabetes, is being observed in North America, creating a strong demand for effective wound management solutions. According to the U.S. Census Bureau, by 2032, all baby boomers will be older than 65, expanding the size of the older population so that 1 in every 5 residents will be of retirement age. The number of Americans ages 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060.

Comprehensive reimbursement policies are also being implemented, ensuring that wound care products are widely accessible to patients. Consequently, these factors are being recognized as crucial drivers of market growth, solidifying North America's position as a leader in the traditional wound care market.

How is the Asia Pacific Region Experiencing Rapid Growth in the Traditional Wound Care Market?

According to VMR analyst, the Asia Pacific region is experiencing rapid growth in the traditional wound care market due to several key factors, including a rising population and increasing awareness of healthcare standards. Economic development in countries such as China and India are leading to improvements in healthcare access and infrastructure, which are fostering greater adoption of wound care products.

Additionally, the growing prevalence of lifestyle-related chronic diseases is resulting in a higher incidence of wounds requiring management. According to the IDF Diabetes Atlas, the number of adults with diabetes in the Western Pacific region was approximately 162.6 million in 2019 and is projected to rise to 260 million by 2045, representing a significant increase of about 27%.

Government initiatives aimed at enhancing healthcare services are also being implemented, thereby supporting market growth. As a result, the Asia Pacific region is being positioned as a rapidly expanding market within the traditional wound care sector, with significant potential for future developments.

Competitive Landscape

The Traditional Wound Care Market's competitive landscape is characterized by a varied range of companies, including technology developers, plant operators, and service providers, all striving for market share in an increasingly dynamic and growing industry.

Some of the prominent players operating in the traditional wound care market include:

3M

Braun Melsungen AG

Coloplast A/S

Convatec Group plc

Dermarite Industries LLC.

Deroyal Industries, Inc.

Hollister Incorporated

Integra Lifesciences Holdings Corporation

Johnson & Johnson Private Limited

Medtronic plc.

Molnlycke Health Care Ab

Paul Hartmann AG

Smith & Nephew plc.

Latest Developments

In April 2024, M Health Care's innovative 3M(TM) Veraflo(TM) Therapy, with both 3M(TM) Veraflo(TM) Cleanse Choice Complete(TM) Dressing and 3M(TM) V.A.C. Veraflo Cleanse Choice(TM) Dressing, received the first-ever Food and Drug Administration (FDA) clearance for hydromechanical removal of infectious materials, non-viable tissue, and wound debris. This reduces the number of surgical debridements required while promoting granulation tissue formation and creating an environment that promotes wound healing.

Traditional Wound Care Market, By Category

  • Product:
  • Gauze
  • Tape
  • Bandage
  • Cotton
  • Application:
  • Chronic Wounds
  • Acute Wounds
  • End-User:
  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Region:
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL TRADITIONAL WOUND CARE MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL TRADITIONAL WOUND CARE MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL TRADITIONAL WOUND CARE MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 Gauze
  • 5.3 Tape
  • 5.4 Bandage
  • 5.5 Cotton

6 GLOBAL TRADITIONAL WOUND CARE MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Chronic Wounds
  • 6.3 Acute Wounds

7 GLOBAL TRADITIONAL WOUND CARE MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Hospital
  • 7.3 Clinic
  • 7.4 Home Healthcare
  • 7.5 Others

8 GLOBAL TRADITIONAL WOUND CARE MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Middle East and Africa
    • 8.5.2 South America

9 GLOBAL TRADITIONAL WOUND CARE MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 3M
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Braun Melsungen AG
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Coloplast A/S
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Convatec Group plc
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Dermarite Industries LLC.
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Deroyal Industries, Inc.
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Hollister Incorporated
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Integra Lifesciences Holdings Corporation
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Johnson & Johnson Private Limited
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Medtronic plc.
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments
  • 10.11 Molnlycke Health Care Ab
    • 10.11.1 Overview
    • 10.11.2 Financial Performance
    • 10.11.3 Product Outlook
    • 10.11.4 Key Developments
  • 10.12 Paul Hartmann AG
    • 10.12.1 Overview
    • 10.12.2 Financial Performance
    • 10.12.3 Product Outlook
    • 10.12.4 Key Developments
  • 10.13 Smith & Nephew plc.
    • 10.13.1 Overview
    • 10.13.2 Financial Performance
    • 10.13.3 Product Outlook
    • 10.13.4 Key Developments

11 APPENDIX

  • 11.1 Related Research